Nicox SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nicox SA with three other
companies in this sector in France:
sales of 2.46 million Euro [US$2.64 million]
(6.17 million Euro [US$6.61 million]
of which 100%
was Research & Development), and
(3.48 million Euro [US$3.73 million]
of which 88%
was Orphan Products Oncology).